Idioma:

Status on Heart Transplantation in China

Hu, Xing-Jian ; Dong, Nian-Guo ; Liu, Jin-Ping ; Li, Fei ; Sun, Yong-Feng ; Wang, Yin

Chinese medical journal, 2015-12, Vol.128 (23), p.3238-3242 [Periódico revisado por pares]

China: Medknow Publications Pvt Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
Status on Heart Transplantation in China
Autor: Hu, Xing-Jian ; Dong, Nian-Guo ; Liu, Jin-Ping ; Li, Fei ; Sun, Yong-Feng ; Wang, Yin
Assuntos: Age ; Blood & organ donations ; Brain death ; Brain research ; Cardiovascular disease ; China ; Company reports ; Demographic aspects ; Donation After Brain Death; Elderly; Heart Transplantation; Marginal Donor Heart; Mechanical Circulatory Support; Pediatric ; Drugs ; Health aspects ; Heart ; Heart surgery ; Heart transplantation ; Heart Transplantation - methods ; Hospitals ; Humans ; Ischemia ; Pediatrics ; Public health ; Science ; Surgeons ; Transplantation ; Transplants & implants ; 心脏移植 ; 患者 ; 手术治疗 ; 疗效
É parte de: Chinese medical journal, 2015-12, Vol.128 (23), p.3238-3242
Notas: INTRODUCTION ＂End-stage heart disease＂ commonly refers to an irreversible stage of cardiac decompensation caused by a variety of pathologies that cannot be treated using conventional drugs or traditional surgical treatments. The life expectancy of patients with end-stage heart disease ranges from 〈6 months to 1 year. Therapeutic strategies for end-stage heart disease patients are primarily based on three approaches： Internal medicine therapy, surgical therapy （heart transplantation）, and multiple organ protection therapy via the core method of mechanical circulation assistance. Among these approaches, heart transplantation has become recognized as the most efl＇ective treatment.
Donation After Brain Death; Elderly; Heart Transplantation; Marginal Donor Heart; Mechanical Circulatory Support;Pediatric
11-2154/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: INTRODUCTION ＂End-stage heart disease＂ commonly refers to an irreversible stage of cardiac decompensation caused by a variety of pathologies that cannot be treated using conventional drugs or traditional surgical treatments. The life expectancy of patients with end-stage heart disease ranges from 〈6 months to 1 year. Therapeutic strategies for end-stage heart disease patients are primarily based on three approaches： Internal medicine therapy, surgical therapy （heart transplantation）, and multiple organ protection therapy via the core method of mechanical circulation assistance. Among these approaches, heart transplantation has become recognized as the most efl＇ective treatment.
Editor: China: Medknow Publications Pvt Ltd
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 4 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Status on Heart Transplantation in China

Hu, Xing-Jian ; Dong, Nian-Guo ; Liu, Jin-Ping ; Li, Fei ; Sun, Yong-Feng ; Wang, Yin

China: Medknow Publications Pvt Ltd

Buscando em bases de dados remotas. Favor aguardar.